US equities |
SPCX $166.88 ▲+4.98% NVDA $236.74 ▲+1.19% MU $1,063.53 ▼-1.06% TSLA $377.19 ▲+1.78% MSFT $525.14 ▲+1.47% SNDK $1,707.23 ▼-0.74% INTC $117.14 ▼-1.83% META $743.20 ▲+2.08%
FinancialContent

Cyclo Therapeutics, Inc. - Common Stock (NQ:CYTH)

0.7206 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cyclo Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Cyclo Therapeutics's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Cyclo Therapeutics Provides Business Update and Reports Full Year 2022 Financial Results
From Cyclo Therapeutics
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Ibio Inc (NYSE: IBIO) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program. 
Via Benzinga
News headline image
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
Via ACCESSWIRE
News headline image
Cyclo Therapeutics Provides Clinical Program Update and Highlights Recent Achievements
From Cyclo Therapeutics, Inc.
Via Business Wire
News headline image
Cyclo Therapeutics to Present at the Virtual Investor 2023 Companies to Watch Event
From Cyclo Therapeutics, Inc.
Via Business Wire
News headline image
Cyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease
From Cyclo Therapeutics, Inc.
Via Business Wire
News headline image
Cyclo Therapeutics Announces Closing of $4.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Cyclo Therapeutics, Inc.
Via Business Wire
News headline image
Cyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
From Cyclo Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Cyclo Therapeutics Announces $4.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Cyclo Therapeutics, Inc.
Via Business Wire
News headline image
Why Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) rose 42% to $0.54 after dipping 56% on Thursday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday ↗
Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Cyclo Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Achievements
From Cyclo Therapeutics
Via Business Wire
News headline image
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday ↗
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. 
Via Benzinga
News headline image
Cyclo Therapeutics Announces Publication of Phase 1 Data for Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1 (NPC1)
From Cyclo Therapeutics, Inc.
Via Business Wire
News headline image
Cyclo Therapeutics Commences Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease
From Cyclo Therapeutics, Inc.
Via Business Wire
News headline image
Cyclo Therapeutics Provides Business Update
From Cyclo Therapeutics, Inc.
Via Business Wire
News headline image
Cyclo Therapeutics, TRACON Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗
The Dow Jones dropped by more than 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
News headline image
Cyclo Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
From Cyclo Therapeutics, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
  
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
  
Via Benzinga
News headline image
Cyclo Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
From Cyclo Therapeutics, Inc.
Via Business Wire
News headline image
Cyclo Therapeutics to Present at the China NPC Association Meeting
From Cyclo Therapeutics, Inc.
Via Business Wire
News headline image
Cyclo Therapeutics to Present at the NNPDF-INPDA Conferences 2022
From Cyclo Therapeutics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >